Correlation Between ZyVersa Therapeutics and Nkarta
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Nkarta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Nkarta into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Nkarta Inc, you can compare the effects of market volatilities on ZyVersa Therapeutics and Nkarta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Nkarta. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Nkarta.
Diversification Opportunities for ZyVersa Therapeutics and Nkarta
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ZyVersa and Nkarta is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Nkarta Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nkarta Inc and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Nkarta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nkarta Inc has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Nkarta go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Nkarta
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to generate 1.45 times more return on investment than Nkarta. However, ZyVersa Therapeutics is 1.45 times more volatile than Nkarta Inc. It trades about -0.03 of its potential returns per unit of risk. Nkarta Inc is currently generating about -0.09 per unit of risk. If you would invest 584.00 in ZyVersa Therapeutics on November 5, 2024 and sell it today you would lose (448.00) from holding ZyVersa Therapeutics or give up 76.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Nkarta Inc
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Nkarta Inc |
ZyVersa Therapeutics and Nkarta Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Nkarta
The main advantage of trading using opposite ZyVersa Therapeutics and Nkarta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Nkarta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nkarta will offset losses from the drop in Nkarta's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Nkarta vs. Monte Rosa Therapeutics | Nkarta vs. Lyell Immunopharma | Nkarta vs. Generation Bio Co | Nkarta vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets |